Good move. You’ve made that hard move twice (including against original Veneto guys). A frivolous lawsuit. It’s easy for us to comment on message boards. It’s harder to live it, do it, correct it, while awaiting SEC effects etc to move forward as you actually plan. And you’re planning big. But wisely with all those companies supporting your vaccine for Covid. Others that look good may later implode. Ngio won’t. It deserves a role.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links